• Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: U.S.

Powershares Dynamic Biotechnology & Genome Portfolio

+ Add to Watchlist

PBE:US

46.3000 USD 0.6200 1.32%

As of 15:12:18 ET on 09/30/2014.

Snapshot for Powershares Dynamic Biotechnology & Genome Portfolio (PBE)

Open: 46.9900 High - Low: 47.0200 - 46.1901 Primary Exchange: NYSE Arca
Volume: 18,798 52-Week Range: 33.0400 - 48.1200 Beta vs DZOTR: 0.9984

ETF Chart for PBE

No chart data available.
  • PBE:US 46.3000
  • 1D
  • 1M
  • 1Y
46.9200
Interactive PBE Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for PBE

PowerShares Dynamic Biotechnology & Genome Portfolio is an exchange-traded fund incorporated in the USA. The Fund seeks investment results that correspond to the price and yield of the Dynamic Biotechnology & Genome Intellidex Index, a fundamentally-weighted index. Securities shown to possess the greatest capital appreciation potential are selected by the Index.

Inception Date: 2005-06-23 Telephone: 1-800-983-0903
Managers: PETER HUBBARD
Web Site: www.powershares.com

Fundamentals for PBE

NAV (on 2014-09-29) 46.9482
Assets (M) (on 2014-09-29) 401.4071
Shares out (M) 8.55
Market Cap (M) 398.94
% Premium -0.06
Average 52-Week % Premium 0.0210
Fund Leveraged N

Dividends for PBE

Dividend Type Income
Dividend Frequency Quarter
Last Dividend Net (on 2014-09-19) 0.0429
Dividend Yield (ttm) 0.59%

Performance for PBE

1-Month -1.71% 1-Year +33.94%
3-Month +7.27% 3-Year +36.45%
Year To Date +27.43% 5-Year +22.48%
Expense Ratio 0.63

Top Fund Holdings for PBE

Filing Date: 09/29/2014
Name Position Value % of Total
Sigma-Aldrich Corp 193,912 26,426,327 6.583%
Regeneron Pharmaceuticals Inc 57,534 20,422,269 5.087%
Amgen Inc 144,690 20,266,728 5.048%
Gilead Sciences Inc 187,459 20,153,717 5.020%
Alexion Pharmaceuticals Inc 119,126 20,007,212 4.984%
Pharmacyclics Inc 162,126 19,542,668 4.868%
Biogen Idec Inc 58,789 19,409,776 4.835%
Illumina Inc 112,438 18,577,006 4.627%
United Therapeutics Corp 93,355 12,389,142 3.086%
Insys Therapeutics Inc 311,441 12,239,631 3.049%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil